PPARα, PPARγ and SREBP-1 pathways mediated waterborne iron (Fe)-induced reduction in hepatic lipid deposition of javelin goby Synechogobius hasta

• Published in: Comparative biochemistry and physiology. Toxicology & pharmacology Vol. 197; pp. 8 - 18
• Main Authors: Chen, Guang-Hui, Luo, Zhi, Chen, Feng, Shi, Xi, Song, Yu-Feng, You, Wen-Jing, Liu, Xu
• Format: Journal Article
• Language: English
• Published: United States Elsevier Inc 01.07.2017
• Subjects: Animals; Enzymes - genetics; Enzymes - metabolism; Female; Fish Proteins - genetics; Fish Proteins - metabolism; Gene Expression Regulation - drug effects; Hepatocytes - drug effects; Hepatocytes - metabolism; Iron; Iron - administration & dosage; Iron - toxicity; Lipid deposition; Lipid metabolism; Lipid Metabolism - drug effects; Liver - drug effects; Liver - metabolism; Male; Perciformes - metabolism; PPAR alpha - genetics; PPAR alpha - metabolism; PPAR gamma - genetics; PPAR gamma - metabolism; Signal Transduction - drug effects; Signaling pathway; Sterol Regulatory Element Binding Protein 1 - genetics; Sterol Regulatory Element Binding Protein 1 - metabolism; Synechogobius hasta; Water Pollutants, Chemical - administration & dosage; Water Pollutants, Chemical - toxicity; DMSO; CPT; F; Iron; MTT; PPAR; T; Signaling pathway; ANOVA; ME; qPCR; Lipid metabolism; Fe; HSI; HSL; ICP-AES; ACC; G6PD; CF; SREBP; H&E; Synechogobius hasta; VSI; 6PGD; GW; TG; Lipid deposition; FAS; SEM; ICDH
• ISSN: 1532-0456; 1878-1659
• DOI: 10.1016/j.cbpc.2017.04.003

The 42-day experiment was conducted to investigate the effects and mechanism of waterborne Fe exposure influencing hepatic lipid deposition in Synechogobius hasta. For that purpose, S. hasta were exposed to four Fe concentrations (0 (control), 0.36, 0.72 and 1.07μM Fe) for 42days. On days 21 and 42, morphological parameters, hepatic lipid deposition and Fe contents, and activities and mRNA levels of enzymes and genes related to lipid metabolism, including lipogenic enzymes (6PGD, G6PD, ME, ICDH, FAS and ACC) and lipolytic enzymes (CPTI, HSL), were analyzed. With the increase of Fe concentration, hepatic Fe content tended to increase but HSI and lipid content tended to decrease. On day 21, Fe exposure down-regulated the lipogenic activities of 6PGD, G6PD, ICDH and FAS as well as the mRNA levels of G6PD, ACCa, FAS, SREBP-1 and PPARγ, but up-regulated CPT I, HSLa and PPARα mRNA levels. On day 42, Fe exposure down-regulated the lipogenic activities of 6PGD, G6PD, ICDH and FAS as well as the mRNA levels of 6PGD, ACCa, FAS and SREBP-1, but up-regulated CPT I, HSLa, PPARα and PPARγ mRNA levels. Using primary S. hasta hepatocytes, specific pathway inhibitors (GW6471 for PPARα and fatostatin for SREBP-1) and activator (troglitazone for PPARγ) were used to explore the signaling pathways of Fe reducing lipid deposition. The GW6471 attenuated the Fe-induced down-regulation of mRNA levels of 6PGD, G6PD, ME, FAS and ACCa, and attenuated the Fe-induced up-regulation of mRNA levels of CPT I, HSLa and PPARα. Compared with single Fe-incubated group, the mRNA levels of G6PD, ME, FAS, ACCa, ACCb and PPARγ were up-regulated while the CPT I mRNA levels were down-regulated after troglitazone pre-treatment; fatostatin pre-treatment down-regulated the mRNA levels of 6PGD, ME, FAS, ACCa, ACCb and SREBP-1, and increased the CPT I and HSLa mRNA levels. Based on these results above, our study indicated that Fe exposure reduced hepatic lipid deposition by down-regulating lipogenesis and up-regulating lipolysis, and PPARα, PPARγ and SREBP-1 pathways mediated the Fe-induced reduction of hepatic lipid deposition in S. hasta.